Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies
An Erratum on
Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies
by Martín-Martín, C., Planchuelo-Gómez, Á., Guerrero, Á. L., García-Azorín, D., Tristán-Vega, A., de Luis-García, R., and Aja-Fernández, S. (2023) Front. Neurosci. 17:1106350. doi: 10.3389/fnins.2023.1106350
Due to a production error, there was a mistake in Figure 4 and Figure 9 as published. Figure 4 had a formatting issue and part of Figure 9B was missing. The corrected Figure 4 and Figure 9 appear below.
The publisher apologizes for this mistake. The original article has been updated.
Keywords: alternative metrics, AMURA, brain, diffusion magnetic resonance imaging, DTI, migraine
Citation: Frontiers Production Office (2023) Erratum: Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies. Front. Neurosci. 17:1228337. doi: 10.3389/fnins.2023.1228337
Received: 24 May 2023; Accepted: 24 May 2023;
Published: 09 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org